PolyPeptide Shares Surge Amid Takeover Interest From EQT, KKR

PolyPeptide Shares Surge Amid Takeover Interest From EQT, KKR

(Bloomberg) — PolyPeptide Group AG shares hit the highest level in more than three years, after people with knowledge of the matter said the Swiss contract drugmaker is attracting private equity takeover interest.

PolyPeptide draws takeover interest from EQT and KKR

Swiss contract development and manufacturing company PolyPeptide Group AG is attracting potential acquisition interest from several private equity firms, including EQT AB and KKR & Co, according to a Bloomberg News report citing unnamed people familiar with the discussions. The reports indicate that other investors, including Advent International, have also been examining a possible buyout of the pharmaceutical services group, which specialises …